Product Innovation in PCCT: the race to reshape the landscape of medical imaging has quietly begun

Is photon-counting CT the next battleground in medical imaging? SIEMENS' PPCT has captured nearly 100% market share in the high-end imaging segment in China.

From January to August this year, the NAEOTOM Alpha won bids from nearly 20 medical institutions, with a total contract value approaching RMB 800M (~$112M), despite its high price of nearly RMB 50M (~$7M) per unit.

While NAEOTOM Alpha represents a breakthrough in imaging performance, dose reduction, and spectral capabilities, it's also challenged by cost, supply, and growing competition.

Watch the next video: Product Innovation in PCCT: what forces are currently challenging SlEMENS' monopoly?